Quinethazone

Quinethazone
Clinical data
AHFS/Drugs.com	Micromedex Detailed Consumer Information
Routes of; administration	Oral
ATC code	C03BA02 (WHO) ;
Legal status
Legal status	In general: ℞ (Prescription only);
Identifiers
	IUPAC name 7-chloro-2-ethyl-4-oxo-1,2,3,4-tetrahydroquinazoline-; 6-sulfonamide;
CAS Number	73-49-4 ;
PubChem CID	6307;
IUPHAR/BPS	7289;
DrugBank	DB01325 ;
ChemSpider	6068 ;
UNII	455E0S048W;
KEGG	D00461 ;
ChEMBL	ChEMBL1532 ;
CompTox Dashboard (EPA)	DTXSID9023548 ;
ECHA InfoCard	100.000.729
Chemical and physical data
Formula	C10H12ClN3O3S
Molar mass	289.739 g/mol g·mol−1
3D model (JSmol)	Interactive image;
	SMILES O=S(=O)(c2c(Cl)cc1c(C(=O)NC(N1)CC)c2)N;
	InChI InChI=1S/C10H12ClN3O3S/c1-2-9-13-7-4-6(11)8(18(12,16)17)3-5(7)10(15)14-9/h3-4,9,13H,2H2,1H3,(H,14,15)(H2,12,16,17) ; Key:AGMMTXLNIQSRCG-UHFFFAOYSA-N ;
(verify)

Quinethazone (INN, brand name Hydromox) is a thiazide-like diuretic used to treat hypertension. Common side effects include dizziness, dry mouth, nausea, and low potassium levels.

References

This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.